Our experiments revealed that KynA treatment downregulates HIF-1α expression levels of protein in colon cancer cells without affecting HIF-1α mRNA expression, indicating a post-transcriptional regulation of HIF-1α (Figure 6A). Here, HIF1A is linked to colonic neoplasm.